OABI Q4 2021 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+14.6% YoY

Gross Profit

$12M78.9% margin

Operating Income

-$3M-21.7% margin

Net Income

-$3M-20.1% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+143.4%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$304M

Total Liabilities

$70M

Stockholders' Equity

$234M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$13M	+14.6%
Gross Profit	$12M	$13M	-9.6%
Operating Income	-$3M	-$2M	-38.4%
Net Income	-$3M	-$159,000	-1832.1%